openPR Logo
Press release

Global Insulin Patch Pump Market to Reach $2281.53 Million by 2030

10-06-2023 12:42 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Triton Market Research

Global Insulin Patch Pump Market

Global Insulin Patch Pump Market

According to Triton's research analysis, the global insulin patch pump market was valued at $1028.80 million in 2022, and is expected to expand at a CAGR of 10.54% from 2023 to 2030.

A study by Triton Market Research titled 'Global Insulin Patch Pump Market' includes the Global Analysis and Forecasts by Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies), by Disease Indication (Type 1 Diabetes, Type 2 Diabetes), by Delivery Mode (Basal & Bolus, Basal, Bolus), by Product Type (Disposable, Reusable), and by Regional Outlook (North America, Europe, Asia-Pacific, Middle East and Africa, Latin America).

Read the Report Summary here:
https://www.tritonmarketresearch.com/reports/insulin-patch-pump-market

Insulin patch pumps are small, wearable medical devices that provide diabetics with insulin. They are a viable alternative to standard insulin pumps, which are often larger and heavier.

Request a Free Sample of the Global Insulin Patch Pump Market Report @ https://www.tritonmarketresearch.com/reports/insulin-patch-pump-market#request-free-sample

Triton Market Research's report forecasts that the global insulin patch pump market will expand at a CAGR of 10.54% from 2023 to 2030, generating a revenue of $2281.53 million by 2030.
Insulin patch pumps are becoming increasingly sophisticated while remaining dependable and lightweight. Smartphone integration has automated insulin delivery, thus making this therapeutic solution more efficient and user-friendly.
With the advent of technology and the increased prevalence of diabetes, insulin patch pumps are poised to revolutionize insulin delivery and provide a practical solution for people requiring insulin therapy. The incorporation of advanced technology is thus propelling the insulin patch pump market.
The market for insulin patch pumps is highly regulated. Medical devices require approval from health authorities to assure long-term safety profiles and patient acceptance. To ensure safety and effectiveness, such devices must meet well-established requirements for accuracy, dependability, cybersecurity, and clinical relevance.
Compliance with these regulations is critical to maintaining high levels of quality and safety for patients. As a result, gaining regulatory approval can be difficult for insulin patch pump manufacturers, thus potentially impeding market expansion over the forecast period.
The insulin patch pump market is mainly divided into distribution channel, disease indication, delivery mode, and product type. Based on distribution channel, the market comprises retail pharmacies, online pharmacies, and hospital pharmacies.
Whereas, based on disease indication, the market includes type 1 diabetes and type 2 diabetes. On the basis of delivery mode, the market consists of basal & bolus, basal, and bolus. Lastly, based on product type, the market comprises disposable and reusable.
Over the forecasted period, the market in North America is expected to expand with the fastest growth rate globally, due to the rising incidence of diabetes, per capita income, and healthcare costs.
Canada has a historic heritage of contributing to substantial improvements in diabetes prevention and treatment, being a hub for famous diabetes researchers, who discovered insulin many years ago. The Canadian government collaborates with many partners and invests in health research to promote diabetes prevention, diagnosis, and treatment. This has significantly enhanced the adoption of insulin patch pumps in the country.
The prominent companies in the insulin patch pump market include CeQur SA, Debiotech SA, Medtrum Technologies Inc, Terumo Corporation, F Hoffmann La Roche AG, Insulet Corporation, EOFlow Co Ltd, Medtronic Plc, and Tandem Diabetes Care Inc.

Purchase this Report @ https://www.tritonmarketresearch.com/reports/insulin-patch-pump-market#purchase-option

Question & Answer: Insulin Patch Pump Market
Question 1: What factor is driving the insulin patch pump market's growth?
Answer: Insulin patch pumps are becoming a practical option for insulin therapy due to their user-friendliness, affordability, and smaller size compared to conventional pumps. Technological advancements have also reduced the need for regular monitoring, increasing demand for these devices. As a result, more patients are opting for insulin patch pumps over conventional pumps. Therefore, the growing awareness of insulin pumps is driving the insulin patch pump market.

Question 2: What factor is a challenge for the market's growth?
Answer: While insulin pumps have gained popularity as a treatment option for diabetes, they come with potential risks, such as low blood sugar, weight gain, hemorrhage, and scarring. These risks are expected to pose a challenge to the market growth during the forecast period.

Question 3: Which region is anticipated to grow the fastest in the global market?
Answer: North America is anticipated to grow at the fastest rate in the global market over the forecast period. The increasing prevalence of diabetes, rising income levels, and escalating healthcare expenses are expected to be the key factors driving the significant expansion of the insulin patch pump market in this region.

Question 4: Which are the prominent players operating in the insulin patch pump market?
Answer: The prominent companies in the insulin patch pump market include CeQur SA, Debiotech SA, Medtrum Technologies Inc, Terumo Corporation, F Hoffmann La Roche AG, Insulet Corporation, EOFlow Co Ltd, Medtronic Plc, and Tandem Diabetes Care Inc.

Related Reports:
GLUCOSE MONITORING SYSTEM MARKET
https://www.tritonmarketresearch.com/search-report/glucose+monitoring+system+market
Triton Market Research has conducted a comprehensive analysis of the glucose monitoring system market, with a focus on several countries, including China, Germany, India, Indonesia, Malaysia, South Korea, the United Kingdom, and Vietnam.
This in-depth report provides valuable insights into the current state and potential growth of the market in these key regions. In the formulation of this report, the forecast years considered are 2019 through 2025. Additionally, the market analysis has included a detailed segmentation based on various factors, such as CGMS Component Type, CGMS End-user, CGMS Demographics, SMBG Type, SMBG End-user, and SMBG Application.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Insulin Patch Pump Market to Reach $2281.53 Million by 2030 here

News-ID: 3238241 • Views:

More Releases from Triton Market Research

Cleanroom Technology Market to Reach $10956.39 Million by 2030
Cleanroom Technology Market to Reach $10956.39 Million by 2030
According to Triton's research, the global cleanroom technology market attained $6691.30 million in 2022 and is anticipated to register a growth rate of 6.31% during 2023-2030. A recent study by Triton Market Research titled Global Cleanroom Technology Market includes the Global Analysis and Forecasts by End-user (Pharmaceutical, Hospitals, Medical Devices, Biotechnology, Semiconductor Manufacturing, Biotechnology, Semiconductor Manufacturing, Other End-users), Component (Consumables [Apparels, Wipes, Disinfectants, Gloves, Other Consumables], Equipment [Vacuum Systems, Desiccator Cabinets,
Growing Obesity Will Drive the Global Cellulite Treatment Market
Growing Obesity Will Drive the Global Cellulite Treatment Market
As per Triton Market Research, the global market for cellulite treatment reaped revenue worth $2225.93 million in 2022, and it is projected to grow at a CAGR of 9.48% from 2023 to 2030. A recent study by Triton Market Research titled 'Global Cellulite Treatment Market' includes the Global Analysis and Forecasts by Procedure Type (Minimally invasive, Topical, Non-invasive), End-user (Beauty centers, Clinics, Other End-users), cellulite type (Edematous Cellulite, Hard Cellulite, Soft
Global Business Jet Market Growth and Trends, 2023-2030
Global Business Jet Market Growth and Trends, 2023-2030
As per Triton's research report, the global business jets market is expected to progress with a CAGR of 4.05% during 2023-2030. A recent study by Triton Market Research titled Global Business Jets Market comprises the Global Analysis and Forecasts by Industry Vertical (OEM, In-House, Third Party), Type (Super Mid-Sized Jets to Business Liners, Middle-Sized Jets, Small Jets), Engine Count (Double Engine, Three Engine, Single Engine), Part (Landing Gear Assemblies, Fuselage/Body, Jet
Botulinum Toxin Growth Prospects, 2023-2030
Botulinum Toxin Growth Prospects, 2023-2030
According to Triton's analysis, the global botulinum toxin market garnered a value of $5796.12 million in 2022 and is estimated to progress at a CAGR of 10.17% during 2023-2030. A recent study by Triton Market Research titled Global Botulinum Toxin Market includes segmented by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users), Product Type (Type B, Type A), Application (Medical [Muscle Spasm, Hyperhidrosis, Overactive Bladder, Chronic Migraine, Other Medical

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Bluetooth connected smart insulin pens represent the future of insulin delivery …
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through the
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin
Insulin Drug and Delivery Technologies Market Report 2018: Segmentation by Produ …
Global Insulin Drug and Delivery Technologies market research report provides company profile for Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
09-06-2017 | Health & Medicine
MRRSE
Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effectiv …
By connectivity, the Bluetooth connected smart insulin pen segment is expected to account for a value share of US$ 0.276 Mn in 2017. The segment is expected to reach a little more than US$ 2 Mn by 2027 end, registering the highest CAGR of 23.2% over the forecast period. Bluetooth connected smart insulin pens represent the future of insulin delivery devices. Such devices have an inbuilt Bluetooth connectivity feature allowing
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact